“…All studies included participants’ views on mpox prevention measures, focusing particularly on: behaviour prior to the onset of symptoms [ 33 ], behaviour and practices from the time of symptom onset to recovery [ 32 ], participants’ experiences of treatment and care [ 35 ], and engagement in primary and/or secondary prevention measures [ 34 ].…”